Justin Bowers
Stock Analyst at Deutsche Bank
(1.77)
# 3,323
Out of 5,005 analysts
40
Total ratings
33.33%
Success rate
4.03%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $328.39 | -4.08% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $532.49 | -19.25% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $206.63 | +28.25% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $9.45 | +143.39% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $20.75 | +39.76% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $12.75 | +96.08% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $148.73 | +4.22% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $543.32 | +12.27% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $62.95 | +30.26% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $14.29 | +74.95% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.09 | +450.16% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $193.89 | +54.73% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $214.99 | +27.91% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $272.56 | -8.28% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $177.33 | +63.54% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $12.93 | +255.76% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $328.39
Upside: -4.08%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $532.49
Upside: -19.25%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $206.63
Upside: +28.25%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $9.45
Upside: +143.39%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $20.75
Upside: +39.76%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $12.75
Upside: +96.08%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $148.73
Upside: +4.22%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $543.32
Upside: +12.27%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $62.95
Upside: +30.26%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $14.29
Upside: +74.95%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.09
Upside: +450.16%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $193.89
Upside: +54.73%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $214.99
Upside: +27.91%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $272.56
Upside: -8.28%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $177.33
Upside: +63.54%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $12.93
Upside: +255.76%